How would you lead a goals of care discussion in terms of prognosis/survival likelihood for patients with inotropic dependent HFrEF with CRT-D on maximally tolerated GDMT?

Topics: Cardiology • Advanced Heart Failure and Transplant

Answer from: at Community Practice

I usually start by reviewing the prognosis with inotrope-dependent HF, quote data from DT VAD trials (REMATCH). I assess the eligibility for DT VAD and transplantation and review the shared decision-making pathways (IDECIDE LVAD) if the patient is eligible for DT VAD. If the patient is not a ca...

Comments

at David Turbay MD PLLC
I wonder if the outcomes are now different than in...

at Harvard Medical School
In 25 years, we have seen outcomes in advanced hea...

Answer from: at Academic Institution

In addressing the nuanced management and prognosis for patients with inotrope-dependent heart failure with reduced ejection fraction (HFrEF), recent scholarly discussions and research findings offer a comprehensive view that aligns with and expands upon the insights shared by esteemed experts Drs. @...

Related Questions